Literature DB >> 25124610

MiR-150-5p suppresses colorectal cancer cell migration and invasion through targeting MUC4.

Wei-Hua Wang1, Jie Chen, Feng Zhao, Bu-Rong Zhang, Hong-Sheng Yu, Hai-Ying Jin, Jin-Hua Dai.   

Abstract

Growing evidence suggests that miR-150-5p has an important role in regulating genesis of various types of cancer. However, the roles and the underlying mechanisms of miR-150-5p in development of colorectal cancer (CRC) remain largely unknown. Transwell chambers were used to analyze effects on cell migration and invasion by miR-150-5p. Quantitative real-time PCR (qRT-PCR), Western blotting and dual-luciferase 3' UTR reporter assay were carried out to identify the target genes of miR-150-5p. In our research, miR-150-5p suppressed CRC cell migration and invasion, and MUC4 was identified as a direct target gene. Its effects were partly blocked by re-expression of MUC4. In conclusiomn, miR-150-5p may suppress CRC metastasis through directly targeting MUC4, highlighting its potential as a novel agent for the treatment of CRC metastasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25124610     DOI: 10.7314/apjcp.2014.15.15.6269

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  16 in total

1.  MicroRNA-506 suppresses growth and metastasis of oral squamous cell carcinoma via targeting GATA6.

Authors:  Li Deng; Hui Liu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Identification of lymph node metastasis-related microRNAs in lung adenocarcinoma and analysis of the underlying mechanisms using a bioinformatics approach.

Authors:  Li Yan; Demin Jiao; Huizhen Hu; Jian Wang; Xiali Tang; Jun Chen; Qingyong Chen
Journal:  Exp Biol Med (Maywood)       Date:  2016-11-14

3.  MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.

Authors:  Chia-Hao Tung; Li-Wei Kuo; Meng-Fan Huang; Yi-Ying Wu; Yao-Tsung Tsai; Jia-En Wu; Keng-Fu Hsu; Yuh-Ling Chen; Tse-Ming Hong
Journal:  Oncogene       Date:  2019-09-30       Impact factor: 9.867

4.  Advances in miRNA-Mediated Mucin Regulation.

Authors:  Shiv Ram Krishn; Surinder K Batra; Sukhwinder Kaur
Journal:  Curr Pharmacol Rep       Date:  2015-01-15

5.  Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.

Authors:  Xiongbo Wu; Min Xia; Dayang Chen; Fang Wu; Zhifa Lv; Qiang Zhan; Yang Jiao; Wenjie Wang; Guangxia Chen; Fangmei An
Journal:  Tumour Biol       Date:  2016-09-22

6.  miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.

Authors:  Tao Li; Junjie Xie; Chuan Shen; Dongfeng Cheng; Yuan Shi; Zhichong Wu; Qian Zhan; Xiaxing Deng; Hao Chen; Baiyong Shen; Chenghong Peng; Hongwei Li; Zhecheng Zhu
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

7.  MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis.

Authors:  Wei Sun; Zhuochao Zhang; Jianlin Wang; Runze Shang; Liang Zhou; Xing Wang; Juanli Duan; Bai Ruan; Yuan Gao; Bin Dai; Shibin Qu; Wei Liu; Rui Ding; Lin Wang; Desheng Wang; Kefeng Dou
Journal:  Oncotarget       Date:  2016-03-08

Review 8.  The Role of MicroRNAs in the Chemopreventive Activity of Sulforaphane from Cruciferous Vegetables.

Authors:  Christopher Dacosta; Yongping Bao
Journal:  Nutrients       Date:  2017-08-19       Impact factor: 5.717

9.  Selective secretion of microRNAs from lung cancer cells via extracellular vesicles promotes CAMK1D-mediated tube formation in endothelial cells.

Authors:  James Lawson; Christopher Dickman; Sara MacLellan; Rebecca Towle; James Jabalee; Stephen Lam; Cathie Garnis
Journal:  Oncotarget       Date:  2017-08-07

10.  Wnt/β-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling.

Authors:  Yan-Hua Guo; Lu-Qin Wang; Bin Li; Hui Xu; Jian-Hua Yang; Li-Si Zheng; Peng Yu; Ai-Dong Zhou; Yin Zhang; Shu-Juan Xie; Zi-Rui Liang; Chen-Min Zhang; Hui Zhou; Liang-Hu Qu
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.